Combretum mucronatum and Capparis thonningii prevent scopolamine-induced memory deficit in mice

References

• Agrawal R, Tyagi E, Saxena G, Nath C. (2009). Cholinergic influence on memory stages: A study on scopolamine amnesic mice. Indian J Pharmacol, 41, 192–196.
   PubMed Web of Science ®Google Scholar
• Ahmed T, Gilani AH. (2009). Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease. Pharmacol Biochem Behav, 91, 554–559.
   PubMed Web of Science ®Google Scholar
• Ajaiyeoba EO, Sama W. (2006). Phytochemical and antimicrobial studies of C. thonningii and C. tormentosa. Pharmacog Mag, 2, 118–122.
   Google Scholar
• Bartus RT. (2000). On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol, 163, 495–529.
   PubMed Web of Science ®Google Scholar
• Bartus RT, Dean RL, 3rdBeer B, Lippa AS. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408–414.
   PubMed Web of Science ®Google Scholar
• Burkhill HM. (1985). The Useful Plants of West Tropical Africa, Vol.1. 2nd edition. UK: White Friars Press.
   Google Scholar
• Colado MI, O’Shea E, Granados R, Misra A, Murray TK, Green AR. (1997). A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol, 121, 827–833.
   PubMed Web of Science ®Google Scholar
• Dringen R, Gutterer JM, Hirrlinger J. (2000). Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem, 267, 4912–4916.
   PubMedGoogle Scholar
• Ebert U, Kirch W. (1998). Scopolamine model of dementia: Electroencephalogram findings and cognitive performance. Eur J Clin Invest, 28, 944–949.
   PubMed Web of Science ®Google Scholar
• Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys, 82, 70–77.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 7, 88–95.
   PubMed Web of Science ®Google Scholar
• El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary Eel-D. (2003). Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav, 76, 525–533.
   PubMed Web of Science ®Google Scholar
• Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, Ding J, Geng M. (2005). Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett, 374, 222–226.
   PubMed Web of Science ®Google Scholar
• Francis PT, Palmer AM, Snape M, Wilcock GK. (1999). The cholinergic hypothesis of Alzheimer’s disease: A review of progress. J Neurol Neurosurg Psychiatry, 66, 137–147.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki Y, Melamed E, Offen D. (2002). Antioxidant treatment in Alzheimer’s disease: Current state. J Mol Neurosci, 21, 1–11.
   Google Scholar
• Giovannini MG, Casamenti F, Bartolini L, Pepeu G. (1997). The brain cholinergic system as a target of cognition enhancers. Behav Brain Res, 83, 1–5.
   Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. (1982). Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem, 126, 131–138.
   PubMed Web of Science ®Google Scholar
• Harvsteen BH. (2002). The biochemistry and medical significance of the flavonoids. Pharmacol Ther, 96, 67–202.
   Google Scholar
• Hermans RH, Hunter DE, McGivern RF, Cain CD, Longo LD. (1992). Behavioral sequelae in young rats of acute intermittent antenatal hypoxia. Neurotoxicol Teratol, 14, 119–129.
   PubMed Web of Science ®Google Scholar
• Jeong EJ, Lee KY, Kim SH, Sung SH, Kim YC. (2008). Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur J Pharmacol, 588, 78–84.
   PubMed Web of Science ®Google Scholar
• Ji HF, Zhang HY. (2006). Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer’s disease. J Mol Struct, 767, 3–9.
   Web of Science ®Google Scholar
• Jones RW, Wesnes KA, Kirby J. (1991). Effects of NMDA modulation in scopolamine dementia. Ann N Y Acad Sci, 640, 241–244.
   PubMed Web of Science ®Google Scholar
• Kulkarni KS, Kasture SB, Mengi SA. (2010). Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats. Indian J Pharmacol, 42, 168–173.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Marcus DL, Thomas C, Rodriquez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML. (1998). Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s disease. Exp Neurol, 150, 40–44.
   PubMed Web of Science ®Google Scholar
• Morris R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods, 11, 47–60.
   PubMed Web of Science ®Google Scholar
• Pachauri SD, Tota S, Khandelwal K, Verma PR, Nath C, Hanif K, Shukla R, Saxena JK, Dwivedi AK. (2012) Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: a behavioral, biochemical and cerebral blood flow study. J Ethnopharmacol, 139, 34–41.
   PubMed Web of Science ®Google Scholar
• Richetti SK, Blank M, Capiotti KM, Piato AL, Bogo MR, Vianna MR, Bonan CD. (2011). Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav Brain Res, 217, 10–15.
   PubMed Web of Science ®Google Scholar
• Riedel W, Hogervorst E, Leboux R, Verhey F, van Praag H, Jolles J. (1995). Caffeine attenuates scopolamine-induced memory impairment in humans. Psychopharmacology (Berl), 122, 158–168.
   PubMed Web of Science ®Google Scholar
• Sharma D, Puri M, Tiwary AK, Singh N, Jaggi AS. (2010). Antiamnesic effect of stevioside in scopolamine-treated rats. Indian J Pharmacol, 42, 164–167.
   PubMed Web of Science ®Google Scholar
• Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C. (2008). Challenges for research on polyphenols from foods in Alzheimer’s disease: Bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem, 56, 4855–4873.
   PubMed Web of Science ®Google Scholar
• Taffe MA, Weed MR, Gold LH. (1999). Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Brain Res Cogn Brain Res, 8, 203–212.
   PubMedGoogle Scholar
• Terry AV Jr, Buccafusco JJ. (2003). The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther, 306, 821–827.
   PubMed Web of Science ®Google Scholar
• Tota S, Kamat PK, Awasthi H, Singh N, Raghubir R, Nath C, Hanif K. (2009). Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res, 199, 235–240.
   PubMed Web of Science ®Google Scholar
• Tota S, Nath C, Najmi AK, Shukla R, Hanif K. (2012). Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: Role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism. Behav Brain Res, 232, 66–76.
   Web of Science ®Google Scholar
• Vafeiadou K, Vauzour D, Spencer JP. (2007). Neuroinflammation and its modulation by flavonoids. Endocr Metab Immune Disord Drug Targets, 7, 211–224.
   PubMedGoogle Scholar
• Ward CP, Redd K, Williams BM, Caler JR, Luo Y, McCoy JG. (2002). Ginkgo biloba extract: Cognitive enhancer or antistress buffer. Pharmacol Biochem Behav, 72, 913–922.
   Google Scholar
• Wang C, Smith RL. (1975). Lowry determination of protein in the presence of Triton X-100. Anal Biochem, 63, 414–417.
   PubMed Web of Science ®Google Scholar
• Yamada K, Komori Y, Tanaka T, Senzaki K, Nikai T, Sugihara H, Kameyama T, Nabeshima T. (1999). Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats. Neuroscience, 88, 281–294.
   PubMed Web of Science ®Google Scholar
• Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, Norton MC, Welsh-Bohmer KA, Breitner JC. (2004). Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County study. Arch Neurol, 61, 82–88.
   PubMed Web of Science ®Google Scholar